lifestyle.longislandreport.org

Health Canada Approves Slenyto® – Extended-Release Melatonin Formulation – as a Prescription Drug for Insomnia in Children with Autism Spectrum disorder and Smith Magenis Syndrome

prnewswire

Health Canada Approves Slenyto® – Extended-Release Melatonin Formulation – as a Prescription Drug for Insomnia in Children with Autism Spectrum disorder and Smith Magenis Syndrome – NEWSnet – News… as it used to be


More Press Releases